 Welcome folks it is in fact Jacob Schup again sitting in for Tom O'Brien. He's a bit under the weather today but he'll be all right. So the S&P 500 we have up about five points the Dow Jones of about 13 Nasdaq down about five today. Let's see here the ES is trading right at 4500 the futures there the Russell futures at 1858 NQ's at 1539 and then the Dow futures at 34950 and always changing. Gold contract trading at 1953 we have some upward pressure with the gold contract as some of the deflation fears in China were kind of dissipating. Silver at 2348 and that essentially brought some upward pressure into the gold market and then we have the copper contract trading at 377. Now Light Street crude oil futures trading at 9159 the Brent at 9438 Tesla 26591 steel dynamics cracking its consolidation on some kind of substantial volume actually it in 98 bucks so stand to see what happens there if we could have rejected that with light volume and really move to the top of its consolidation I think that would have been a beauty we'll see what happens for a few months now since you know basically in June it really hasn't cracked that consolidation level the $100 mark with any substantial volume it's kissed it a little bit but it's coming right back and it's the first time we've really broken down past it with some volume so not a great look for steel dynamics as it stands now the dollar at 10517 the Q's 370 Google trading 139 Meta 301 Disney doing a little a little bit better right back from that 79 area and we were trading currently at 8526 Raymond James put out a good analysis of them saying that streaming probably have positive revenue so currently they're doing a one dollar subscription for streaming to try to get people on to their service and then Apple at 17867 okay so what are we looking at right now I want to look at Nova Nordisk they have some interesting stuff going on starting this year we're coming about that 137 level 138 their stock shot all the way up to 200 176 and this gap up was on substantial volume and this is from Ozenpik which is one of their drugs for obesity and same with Govy obviously the Americans love this and Nova Nordisk is actually massive you know it's Europe's second most valuable company but this company itself is single-handedly carrying the economy of Denmark it's very fascinating Denmark's GDP from this grew 1.7% in the first half of this year but might have contracted but weren't for the company at Nova Nordisk share prices up over 40% this year as of Friday's closed taking its market capitalization to 2.6 trillion that's in Danish Kroner and that's 379 billion in USD this is again from Ozenpik and will go V some other companies as well who have obesity drugs that are promising and it is sending their stocks skyrocketing so now what's happening with it well today you can see it's down about 2% and the FDA has reportedly found objectionable conditions at a Kiwi Govy plant now and the short term that's bad right and we'll read a little bit on this article now there's nothing wrong with the drugs themselves and their concept but still this FDA report is not great for them and we might finish down probably about 2% today the volume honestly was not substantial for this and this is much more of like a running headline but it's going to keep in mind as well you're holding Nova Nordisk and you're not really sure what the dive is for so according to Reuters which said at a market-wired news report the FDA inspectors filed a form 483 following their inspection of Nova Nordisk Clayton North Carolina manufacturing plant that form lists any conditions the inspector found that could violate the FDA excuse me the Food and Drug Cosmetic Act and related acts. Nova Nordisk Clayton Plant is one of three between Clayton and Durham responsible for making the diabetes and weight loss drugs and that is will go V and Ozenpik respectively like Somalgotu so for instance Somalgotu cells as injections and this is Ozenpik and will go V and as an oral medicine called Ryobelsus Ozenpik and Ryobelsus treat diabetes while will go V as an increasingly popular weight loss drug the inspection isn't listed on the FDA's inspection database but the agency notes that not all inspections are included in the database for example inspections waiting for a final enforcement action are not listed the FDA generally does not discuss possible completed inspections except with the company involved Nova Nordisk spokeswoman said that the company does not publicly share details so that's why they dropped a little bit today I don't think this is going to be a permanent issue for them whatsoever their drugs are still in a very high demand and as the rest of the world continues to modernize and obesity becomes a bigger risk for them you know you think in China and even Mexico as well I think Mexico is the most obese nation these kind of drugs will be exceedingly popular next on the list want to talk a little bit about Nikola be one second here I think their ticker is NKLA so they had a huge pump up today yes it did I clicked the wrong thing give me a second anyways they have a new COO and this shot the stock up pretty substantially and we'll talk about that they're up 33% today now famously this company got shot down their founder and former CEO essentially lied about nearly all spat excuse me all aspects of the business and was charged with two counts of securities fraud and that was from a United States grand excuse me federal grand jury this really sent the company down quite a bit there's a lot of hype surrounding this company as a competitor for Tesla and it didn't shake out that way they have some other interesting news as well before we get to the COO the CEO has come out and said these see their first hydrogen fuel cell trucks being delivered by the end of the month which is pretty impressive now they did also have a essentially a battery recall but he doesn't think that that's going to really impact the company we'll get this article back when we return we actually have Steve Rhodes back as well he's you know Mr. Global and he's gonna tell us a little bit about his trip and go through some stocks he's looking at so folks stay tuned